Advanced Filter

Filter by Group

Filter by Market Availability

Clear
Displaying drugs 7051 - 7075 of 9780 in total

Copper(II) dithiosemicarbazone

Experimental
Investigational

p-Toluenesulfonamide

Investigational

Mezigdomide

Mezigdomide is under investigation in clinical trial NCT05372354 (A Study to Evaluate Safety, Drug Levels and Effectiveness of CC-92480 (BMS-986348) in Combination With Other Treatments in Participants With Relapsed or Refractory Multiple Myeloma).
Investigational

RP-L201

Investigational

Tasosartan

Tasosartan is a long-acting angiotensin II (AngII) receptor blocker. Its long duration of action has been attributed to its active metabolite enoltasosartan. It is used to treat patients with essential hypertension.
Experimental

alpha-D-glucopyranosyl-2-carboxylic acid amide

Experimental

N-hexadecanoylglycine

Experimental

(1S)-2-[(2S,5R)-2-(AMINOMETHYL)-5-ETHYNYLPYRROLIDIN-1-YL]-1-CYCLOPENTYL-2-OXOETHANAMINE

Experimental

Talviraline

Talviraline has been used in trials studying the treatment of HIV Infections.
Investigational

NAM NAPTHYLAMINOALANINE

Experimental

Firocoxib

Firocoxib is a cycooxygenase-2 (COX-2) selective non-steroidal anti-inflammatory drug. It currently approved for veterinary use in dogs and horses under the brand names Equioxx and Previcox. Firocoxib was the first COX-2 inhibitor approved by the U.S. Food and Drug Administration for horses. Firocoxib is not intended or approved for use...
Experimental
Vet approved

Indobufen

Indobufen has been used in trials studying the supportive care and prevention of Atrial Fibrillation.
Investigational

Opaganib

Opaganib, also known as ABC294640, is a selective sphingosine kinase-2 (SK2) (https://go.drugbank.com/polypeptides/Q9NRA0) inhibitor that is orally administered. This drug has potential anticancer, anti-inflammatory, and antiviral activities, with potential applications in oncology, inflammation, the gastrointestinal system, and COVID-19.
Investigational

S-{2-[(2-chloro-4-sulfamoylphenyl)amino]-2-oxoethyl} 6-methyl-3,4-dihydroquinoline-1(2H)-carbothioate

Experimental

(1-Methyl-1h-Imidazol-2-Yl)-(3-Methyl-4-{3-[(Pyridin-3-Ylmethyl)-Amino]-Propoxy}-Benzofuran-2-Yl)-Methanone

Experimental

2,2-Dichloro-1-methanesulfinyl-3-methyl-cyclopropanecarboxylic acid [1-(4-bromo-phenyl)-ethyl]-amide

Experimental

N-{2,2-DIFLUORO-2-[(2R)-PIPERIDIN-2-YL]ETHYL}-2-[2-(1H-1,2,4-TRIAZOL-1-YL)BENZYL][1,3]OXAZOLO[4,5-C]PYRIDIN-4-AMINE

Experimental

6-BROMO-13-THIA-2,4,8,12,19-PENTAAZATRICYCLO[12.3.1.1~3,7~]NONADECA-1(18),3(19),4,6,14,16-HEXAENE 13,13-DIOXIDE

Experimental

Ethyl Oxo(Piperidin-1-Yl)Acetate

Experimental

Selenomethionine Selenoxide

Experimental

MF268

Experimental

Coelenteramide

Experimental

Manitimus

FK778, a novel compound with multiple mechanisms of action, is efficacious, well tolerated and safe in kidney transplant patients, potentially offering a breakthrough in immunosuppressive therapy.
Investigational

9,9,9-TRIFLUORO-8-OXO-N-PHENYLNONANAMIDE

Experimental

(1S)-1-Phenylethyl (4-acetamidobenzyl)phosphonate

Experimental
Displaying drugs 7051 - 7075 of 9780 in total